Dmytro Butov
About
In The Last Decade
Dmytro Butov
50 papers receiving 311 citations
Peers
Comparison fields: 5 of 78
- Infectious Diseases 173
- Epidemiology 118
- Surgery 80
- Immunology 54
- Molecular Biology 42
Countries citing papers authored by Dmytro Butov
This map shows the geographic impact of Dmytro Butov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dmytro Butov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dmytro Butov more than expected).
Fields of papers citing papers by Dmytro Butov
This network shows the impact of papers produced by Dmytro Butov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dmytro Butov. The network helps show where Dmytro Butov may publish in the future.
Co-authorship network of co-authors of Dmytro Butov
This figure shows the co-authorship network connecting the top 25 collaborators of Dmytro Butov. A scholar is included among the top collaborators of Dmytro Butov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dmytro Butov. Dmytro Butov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | 22 | |
| 6 | 7 | |
| 7 | 2 | |
| 8 | 12 | |
| 9 | 9 | |
| 10 | 0 | |
| 11 | 6 | |
| 12 | 3 | |
| 13 | 2 | |
| 14 | 5 | |
| 15 | 16 | |
| 16 | 9 | |
| 17 | 6 | |
| 18 | 16 | |
| 19 | Efficacy and safety of phytoconcentrate Dzherelo (Immunoxel) in treatment of patients with multi-drug resistant TB (MDR-TB) in comparison to standard chemotherapy. | 7 |
| 20 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.